Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CTAQ Stock Summary
In the News
CTAQ Financial details
Company Rating
Neutral
Market Cap
0
Income
12.61M
Revenue
0
Book val./share
7.58
Cash/share
7.9
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
30 Mar 2021
P/E
37.01
Forward P/E
-
PEG
-
P/S
-
P/B
1.34
P/C
-
P/FCF
-
Quick Ratio
419.47
Current Ratio
0.2
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
0.25
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
9.69%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
3%
ROE
4%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.75-10.64
52W High
-
52W Low
-
RSI
-
Rel Volume
5.01
Avg Volume
68.67K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
CTAQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2020-12-31 | 2021-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | 0 | 0.14 | |
Operating cash flow per share | 0 | -0.02 | |
Free cash flow per share | 0 | -0.02 | |
Cash per share | 0.02 | 7.86 | |
Book value per share | 7.59 | 7.38 | |
Tangible book value per share | 7.59 | 7.38 | |
Share holders equity per share | 7.59 | 7.38 | |
Interest debt per share | 0 | 0 | |
Market cap | 528.51M | 501.88M | |
Enterprise value | 527.68M | 501.81M | |
P/E ratio | 0 | 70.53 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | 0 | -625.06 | |
PFCF ratio | 0 | -625.06 | |
P/B Ratio | 1.36 | 1.33 | |
PTB ratio | 1.36 | 1.33 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | 0 | -51.62 | |
EV to operating cash flow | 0 | -624.97 | |
EV to free cash flow | 0 | -624.97 | |
Earnings yield | 0 | 0.01 | |
Free cash flow yield | 0 | 0 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 0 | 0.01 | |
Current ratio | 16.92 | 1.5 | |
Interest coverage | 0 | 0 | |
Income quality | 0 | -0.11 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 0 | 4.8 | |
ROIC | 0 | 0 | |
Return on tangible assets | 0 | 0.02 | |
Graham Net | -0.28 | 7.38 | |
Working capital | 1.45M | 132.45K | |
Tangible asset value | 388.81M | 378.1M | |
Net current asset value | -13.69M | -24.47M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 0 | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | 0.02 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.09 | -0.04 | 0.17 | 0.05 | 0.06 | |
Operating cash flow per share | 0 | -0.01 | -0.01 | 0 | 0 | |
Free cash flow per share | 0 | -0.01 | -0.01 | 0 | 0 | |
Cash per share | 0.01 | 0 | 7.86 | 7.87 | 7.9 | |
Book value per share | 9.21 | -0.59 | 7.47 | 7.53 | 7.58 | |
Tangible book value per share | 9.21 | 9.19 | 7.47 | 7.53 | 7.58 | |
Share holders equity per share | 9.21 | -0.59 | 7.47 | 7.53 | 7.58 | |
Interest debt per share | 0 | 0.01 | -0.18 | -0.06 | -0.07 | |
Market cap | 402.04M | 403.27M | 502.91M | 504.44M | 510.08M | |
Enterprise value | 401.72M | 403.2M | 503M | 504.48M | 510.07M | |
P/E ratio | 27.21 | -68.4 | 14.87 | 45 | 45.11 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.74K | -1.65K | -1.25K | -1.98K | -3.06K | |
PFCF ratio | -2.74K | -1.65K | -1.25K | -1.98K | -3.06K | |
P/B Ratio | 1.06 | -16.53 | 1.31 | 1.31 | 1.31 | |
PTB ratio | 1.06 | -16.53 | 1.31 | 1.31 | 1.31 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 108.76 | -417.81 | -101.86 | -173.08 | -247.34 | |
EV to operating cash flow | -2.74K | -1.65K | -1.25K | -1.98K | -3.06K | |
EV to free cash flow | -2.74K | -1.65K | -1.25K | -1.98K | -3.06K | |
Earnings yield | 0.01 | 0 | 0.02 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.09 | 0.08 | -0.02 | -0.01 | 0 | |
Current ratio | 4.7 | 9.56 | 2.57 | 1 | 0.2 | |
Interest coverage | 0 | -0.9 | 0.03 | 0.1 | 0.08 | |
Income quality | -0.04 | 0.25 | -0.09 | -0.09 | -0.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.31 | 0.69 | 5.27 | 3.04 | 3.07 | |
ROIC | 0 | 0.03 | 0 | 0 | 0 | |
Return on tangible assets | 0.01 | 0 | 0.02 | 0.01 | 0.01 | |
Graham Net | -0.58 | -0.61 | 7.47 | 7.52 | 7.58 | |
Working capital | 588.5K | 356.78K | 266.08K | 1.56K | -771.31K | |
Tangible asset value | 379.06M | 378.1M | 382.64M | 385.44M | 388.27M | |
Net current asset value | -23.46M | -24.47M | -19.9M | -17.51M | -16.41M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | 0.06 | 0.02 | 0.01 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CTAQ Frequently Asked Questions
What is Carney Technology Acquisition Corp. II stock symbol ?
Carney Technology Acquisition Corp. II is a US stock , located in Palo alto of Ca and trading under the symbol CTAQ
What is Carney Technology Acquisition Corp. II stock quote today ?
Carney Technology Acquisition Corp. II stock price is $- today.
Is Carney Technology Acquisition Corp. II stock public?
Yes, Carney Technology Acquisition Corp. II is a publicly traded company.